Xeris Pharmaceuticals Stock Probability of Future Stock Price Finishing Over 3.38
| XERS Stock | USD 3.38 0.10 3.05% |
Closest to current price Xeris long CALL Option Payoff at Expiration
Xeris |
Xeris Pharmaceuticals Target Price Odds to finish over 3.38
The tendency of Xeris Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 3.38 | 90 days | 3.38 | nearly 4.21 |
Based on a normal probability distribution, the odds of Xeris Pharmaceuticals to move above the current price in 90 days from now is nearly 4.21 (This Xeris Pharmaceuticals probability density function shows the probability of Xeris Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days the stock has the beta coefficient of 1.01 . This entails Xeris Pharmaceuticals market returns are related to returns on the market. As the market goes up or down, Xeris Pharmaceuticals is expected to follow. Additionally Xeris Pharmaceuticals has an alpha of 0.2017, implying that it can generate a 0.2 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Xeris Pharmaceuticals Price Density |
| Price |
Predictive Modules for Xeris Pharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Xeris Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Xeris Pharmaceuticals Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Xeris Pharmaceuticals is not an exception. The market had few large corrections towards the Xeris Pharmaceuticals' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Xeris Pharmaceuticals, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Xeris Pharmaceuticals within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.20 | |
β | Beta against Dow Jones | 1.01 | |
σ | Overall volatility | 0.22 | |
Ir | Information ratio | 0.07 |
Xeris Pharmaceuticals Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Xeris Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Xeris Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Xeris Pharmaceuticals has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 163.91 M. Net Loss for the year was (62.26 M) with profit before overhead, payroll, taxes, and interest of 87.61 M. | |
| Xeris Pharmaceuticals currently holds about 111.55 M in cash with (47.02 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.82. | |
| Xeris Pharmaceuticals has a poor financial position based on the latest SEC disclosures | |
| Latest headline from businesswire.com: Xeris to Participate in Piper Sandler 36th Annual Healthcare Conference |
Xeris Pharmaceuticals Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Xeris Stock often depends not only on the future outlook of the current and potential Xeris Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Xeris Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 137.7 M | |
| Cash And Short Term Investments | 72.5 M |
Xeris Pharmaceuticals Technical Analysis
Xeris Pharmaceuticals' future price can be derived by breaking down and analyzing its technical indicators over time. Xeris Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Xeris Pharmaceuticals. In general, you should focus on analyzing Xeris Stock price patterns and their correlations with different microeconomic environments and drivers.
Xeris Pharmaceuticals Predictive Forecast Models
Xeris Pharmaceuticals' time-series forecasting models is one of many Xeris Pharmaceuticals' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Xeris Pharmaceuticals' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Xeris Pharmaceuticals
Checking the ongoing alerts about Xeris Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Xeris Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Xeris Pharmaceuticals has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 163.91 M. Net Loss for the year was (62.26 M) with profit before overhead, payroll, taxes, and interest of 87.61 M. | |
| Xeris Pharmaceuticals currently holds about 111.55 M in cash with (47.02 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.82. | |
| Xeris Pharmaceuticals has a poor financial position based on the latest SEC disclosures | |
| Latest headline from businesswire.com: Xeris to Participate in Piper Sandler 36th Annual Healthcare Conference |
Additional Tools for Xeris Stock Analysis
When running Xeris Pharmaceuticals' price analysis, check to measure Xeris Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Xeris Pharmaceuticals is operating at the current time. Most of Xeris Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Xeris Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Xeris Pharmaceuticals' price. Additionally, you may evaluate how the addition of Xeris Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.